NASDAQ-listed AGAPE ATP Corporation (“ATPC”) is pleased to announce the successful completion of its $23 million (USD) private placement exercise, reinforcing its financial strength as the company accelerates expansion into healthcare, oil & gas trading, and renewable energy. The strong participation of institutional investors reflects confidence in ATPC’s long-term growth strategy, positioning the company for sustained market leadership across multiple industries.
To recap, the private placement involved the issuance of 46 million shares of common stock at USD 0.50 per share, under Regulation S of the U.S. Securities Act, which governs offerings to non-U.S. investors. The capital raised will be utilized to support ATPC’s high-growth initiatives, including advancing oil & gas trading projects, scaling up its solar energy ventures, and enhancing its healthcare and wellness solutions.
Prof Dato’ Sri Dr How Kok Choong, the Founder and Global Group CEO of ATPC expressed gratitude for the overwhelming support from new and existing investors, stated: “The successful completion of this private placement is a testament to the strong market confidence in ATPC’s vision and execution strategy. We are deeply grateful for the trust placed in us by institutional investors, which allows us to accelerate our expansion into high-value industries. With this fresh capital, we are well-positioned to enhance our operational capabilities, drive innovation, and create long-term value for our shareholders.”
The completion of this funding round marks a pivotal moment for ATPC as it moves forward with several key initiatives. In the energy sector, ATPC’s strategic partnership with Swiss One Oil & Gas AG is driving the procurement and distribution of refined fuel products, including EN590 10PPM diesel and Jet Fuel A1.
In addition to supporting its energy-related initiatives, ATPC will also utilize the proceeds to enhance its healthcare segment, further expanding its wellness and medical solutions to new markets. The capital infusion will strengthen product innovation, regulatory approvals, and commercialization efforts across ATPC’s diverse portfolio.
